Articles with public access mandates - resham bhattacharyaLearn more
OverallNIHDoDNSFAHASNSFUSEDVAHHMIFWFDFGDBTTelethonVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKParkinson's UKWellcomeWorldwide Cancer Research, UKDoris Duke Charitable FoundationDamon Runyon Cancer Research FoundationFlorida Department of Health, USA
Available somewhere: 83
Role of TGF-β signaling in uterine carcinosarcoma
SKD Dwivedi, SD McMeekin, K Slaughter, R Bhattacharya
Oncotarget 6 (16), 14646, 2015
Mandates: US National Institutes of Health
Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells
G Rao, B Murphy, A Dey, SKD Dwivedi, Y Zhang, RV Roy, P Chakraborty, ...
The FASEB Journal, 2020
Mandates: US National Institutes of Health
Mitochondrial BMI1 maintains bioenergetic homeostasis in cells
SB Mustafi, N Aznar, SK Dhar Dwivedi, PK Chakraborty, R Basak, ...
The FASEB Journal 30 (12), 4042-4055, 2016
Mandates: US National Institutes of Health
Multifunctional APJ pathway promotes ovarian cancer progression and metastasis
D Neelakantan, S Dogra, B Devapatla, P Jaiprasart, MC Mukashyaka, ...
Molecular Cancer Research 17 (6), 1378-1390, 2019
Mandates: US National Institutes of Health
NHERF-2 maintains endothelial homeostasis
R Bhattacharya, E Wang, SK Dutta, PK Vohra, G E, YS Prakash, ...
Blood, The Journal of the American Society of Hematology 119 (20), 4798-4806, 2012
Mandates: US National Institutes of Health
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
CK Elechalawar, MN Hossen, P Shankarappa, CJ Peer, WD Figg, ...
International Journal of Nanomedicine 15, 991, 2020
Mandates: US National Institutes of Health
Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
M Cybula, L Wang, L Wang, AL Drumond-Bock, KM Moxley, ...
Cancers 13 (24), 6288, 2021
Mandates: US National Institutes of Health
Small Non-Coding-RNA in Gynecological Malignancies
SKD Dwivedi, G Rao, A Dey, P Mukherjee, JD Wren, R Bhattacharya
Cancers 13 (5), 1085, 2021
Mandates: US Department of Defense, US National Institutes of Health
BMI1, a new target of CK2α
SB Mustafi, PK Chakraborty, SKD Dwivedi, K Ding, KM Moxley, ...
Molecular Cancer 16 (1), 56, 2017
Mandates: US National Institutes of Health
A core-shell nanomaterial with endogenous therapeutic and diagnostic functions
CR Patra, Y Jing, YH Xu, R Bhattacharya, D Mukhopadhyay, JF Glockner, ...
Cancer nanotechnology 1 (1), 13-18, 2010
Mandates: US National Institutes of Health
Inhibition of bmi1, a therapeutic approach in endometrial cancer
M Buechel, A Dey, SKD Dwivedi, A Crim, K Ding, R Zhang, P Mukherjee, ...
Molecular cancer therapeutics 17 (10), 2136-2143, 2018
Mandates: US National Institutes of Health
Cystathionine β-synthase is necessary for axis development in vivo
S Prabhudesai, C Koceja, A Dey, S Eisa-Beygi, NR Leigh, R Bhattacharya, ...
Frontiers in Cell and Developmental Biology 6, 14, 2018
Mandates: US National Institutes of Health
Ubiquitin‐binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer
X Xiong, G Rao, RV Roy, Y Zhang, N Means, A Dey, M Tsaliki, S Saha, ...
The FASEB Journal 34 (9), 12024-12039, 2020
Mandates: US National Institutes of Health
Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β
Y Wang, LH Hoeppner, RS Angom, E Wang, S Dutta, HR Doeppler, ...
Journal of Biological Chemistry 294 (43), 15759-15767, 2019
Mandates: US National Institutes of Health, American Heart Association, Florida …
Probing cellular processes using engineered nanoparticles
MN Hossen, B Murphy, L Garcı́a-Hevia, R Bhattacharya, P Mukherjee
Bioconjugate chemistry 29 (6), 1793-1808, 2018
Mandates: US National Institutes of Health
KRCC1: A potential therapeutic target in ovarian cancer
SKD Dwivedi, K Shameer, A Dey, SB Mustafi, X Xiong, U Bhattacharya, ...
The FASEB Journal 34 (2), 2287-2300, 2020
Mandates: US National Institutes of Health
Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth
MN Hossen, L Wang, SKD Dwivedi, Y Zhang, G Rao, CK Elechalwar, ...
Advanced Science, 2200491, 2022
Mandates: US National Science Foundation, US National Institutes of Health
Targeting the TGFβ pathway in uterine carcinosarcoma
SKD Dwivedi, G Rao, A Dey, M Buechel, Y Zhang, M Zhang, D Yang, ...
Cell Stress 4 (11), 252, 2020
Mandates: US National Institutes of Health
Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19
Y Zhang, C Xu, NIA Higuita, R Bhattacharya, JH Chakrabarty, ...
Cell stress 6 (1), 6, 2022
Mandates: US National Institutes of Health
Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness
Y Zhang, CK Elechalawar, W Yang, AN Frickenstein, S Asfa, KM Fung, ...
Materials Today, 2022
Mandates: US National Science Foundation, US National Institutes of Health
Publication and funding information is determined automatically by a computer program